Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture

BACKGROUND: Angiogenesis inhibitors (AIs) combination with cytotoxic chemotherapy is a promising treatment for patients with colorectal cancer (CRC). Aflibercept (AFL) is an option for second-line treatment of CRC, according to the ‘VELOUR’ trial. Currently, we can choose from three AIs, including b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastrointest Oncol
Hlavní autoři: Yoshida, Taichi, Takahashi, Kentaro, Shibuya, Kengo, Muto, Osamu, Yoshida, Yuko, Taguchi, Daiki, Shimazu, Kazuhiro, Fukuda, Koji, Ono, Fuminori, Nomura, Kyoko, Shibata, Hiroyuki
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2021
Témata:
Observational Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040061/
https://ncbi.nlm.nih.gov/pubmed/33889280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v13.i4.295
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky